Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 8/20 | 0.49 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1548264 | 1.00 | CXCR4 (0.49) | CXCR4CXCL12EPHX1KDM4ERAD52 | |
| SCHEMBL3537998 | 1.00 | CXCR4 (0.49) | CXCR4CXCL12EPHX1KDM4ERAD52 | |
| SCHEMBL3541152 | 0.98 | CXCR4 (0.46) | CXCR4CXCL12EPHX1KDM4ERAD52 | |
| SCHEMBL4397999 | 0.93 | EPHX1 (0.55) | CXCR4CXCL12EPHX1KDM4EHRH4 | |
| SCHEMBL9949582 | 0.93 | EPHX1 (0.55) | CXCR4CXCL12EPHX1KDM4EHRH4 | |
| SCHEMBL9950898 | 0.93 | EPHX1 (0.55) | CXCR4CXCL12EPHX1KDM4EHRH4 | |
| SCHEMBL9949345 | 0.93 | — | — | |
| SCHEMBL10776080 | 0.91 | EPHX1 (0.58) | CXCR4CXCL12EPHX1KDM4EHRH4 | |
| SCHEMBL7801110 | 0.91 | EPHX1 (0.58) | CXCR4CXCL12EPHX1KDM4EHRH4 | |
| SCHEMBL5217162 | 0.91 | EPHX1 (0.52) | CXCR4CXCL12EPHX1KDM4EHRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9409119-B2 | Acid gas absorbent, acid gas removal method, and acid gas removal device | KABUSHIKI KAISHA TOSHIBA (JP) | 2016-08-09 | — | — | US | disclosed |
| EP-2705894-A1 | Acid gas absorbent, acid gas removal method and acid gas removal device | Kabushiki Kaisha Toshiba (JP) | 2014-03-12 | — | — | EP | disclosed |
| US-20120161071-A1 | ACID GAS ABSORBENT, ACID GAS REMOVAL METHOD, AND ACID GAS REMOVAL DEVICE | KABUSHIKI KAISHA TOSHIBA (JP) | 2012-06-28 | — | — | US | disclosed |
| EP-2468385-A2 | Acid gas absorbent, acid gas removal method and acid gas removal device | Kabushiki Kaisha Toshiba (JP) | 2012-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120161071-A1 | ACID GAS ABSORBENT, ACID GAS REMOVAL METHOD, AND ACID GAS REMOVAL DEVICE | ALKBH1, ALKBH3, ALKBH2 | CXCR4 1697/4885CXCL12 3240/4885EPHX1 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.